Iovance Biotherapeutics (NASDAQ: IOVA) shares are trading higher on Monday after the company completed its Biologics License Application submission for lifileucel.
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Piper Sandler analyst Joseph Catanzaro upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Neutral to Overweight and raises the price target from $11 to $14.
Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…